Author

Maria T. Abreu 1

1 University of Miami Miller School,Miami,United States

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED INFLAMMATORY BOWEL DISEASE RELATED QUALITY OF LIFE IN A PHASE 2 TRIAL OF MIRIKIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS

Marla C. Dubinsky, Scott D. Lee, Remo Panaccione, Maria T. Abreu, Severine Vermeire, Trevor Lissoos, Nathan Morris, Vipin Arora, Mingyang Shan, April Naegeli, Bruce E. Sands

BASELINE AND EARLY PREDICTORS OF RESPONSE TO RISANKIZUMAB INDUCTION AND MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE

Jean-Frédéric Colombel, Walter Reinisch, Stefan Schreiber, Silvio Danese, Ken Sugimoto, Maria T. Abreu, Naomi Martin, Kristina Kligys, Valerie Pivorunas, Alexandra Song, Javier Zambrano, Yafei Zhang, Remo Panaccione

Best of IBD

Maria T. Abreu

Closing the gap: Negotiating for physicians and scientists

Maria T. Abreu

CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION

Ramesh P. Arasaradnam, Ellen J. Scherl, David Rowbotham, Silvio Danese, William J. Sandborn, Ye Miao, Hongyan Zhang, Remo Panaccione, Waqqas Afif, Tadakazu Hisamatsu, Rupert W Leong, Bruce E. Sands, Maria T. Abreu, Colleen W. Marano

Diagnostic strategy to make a confident diagnosis of IBD

Maria T. Abreu

Early Improvement After Intravenous Ustekinumab Induction in Patients with Ulcerative Colitis: Results from the UNIFI Induction Trial

Bruce E. Sands, Maria T. Abreu, C Marano, Thomas Baker, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, David Rowbotham, Rupert W Leong, Silvio Danese

EARLY SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT-1 INDUCTION TRIAL

Silvio Danese, Axel Dignass, Katsuyoshi Matsuoka, Marc Ferrante, Millie Long, Isabel Redondo, Theresa Hunter Gibble, Richard Moses, Nathan Morris, Xingyuan Li, Catherine Milch, Maria T. Abreu

EFFECT OF USTEKINUMAB MAINTENANCE THERAPY ON STOOL FREQUENCY AND RECTAL BLEEDING THROUGH 2 YEARS IN THE UNIFI PHASE 3 STUDY IN ULCERATIVE COLITIS

Laurent Peyrin-Biroulet, Maria T. Abreu, Silvio Danese, Colleen W. Marano, Yiying Zhou, Hongyan Zhang, Rupert W Leong, David Rowbotham, Remo Panaccione, William Sandborn

EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE

Bruce E. Sands, William Sandborn, Laurent Peyrin-Biroulet, Peter Higgins, Fumihito Hirai, Vipul Jairath, Geert R. D'Haens, Maria T. Abreu, Ruth Belin, Elisa Gomez Valderas, Debra Miller, April Naegeli, Vipin Arora, Paul Pollack, Jay Tuttle, Toshifumi Hibi

Item 1 - 10 / 27
1
2 3